[0JBU] YoY Quarter Result on 31-Dec-2024 [#Q4]

Stock
[0JBU] Intellia Therapeutics, Inc.
Announcement Date
27-Feb-2025
Financial Year
2024
Quarter
31-Dec-2024 [#Q4]
Profit Trend
QoQ- 5.02%
YoY- 2.47%
Quarter Report
0JBU's Result
0JBU's Financial Summary
View:
Show?
Quarter Result
31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
Revenue 12,874 -1,917 13,573 12,854 6,595 10,936 7,880 8.51%
PBT -128,898 -132,161 -113,407 -81,237 -42,192 -28,276 -19,066 37.46%
Tax 0 0 3,320 0 0 0 0 -
NP -128,898 -132,161 -116,727 -81,237 -42,192 -28,276 -19,066 37.46%
Tax Rate - - - - - - - -
Total Cost 141,772 130,244 130,300 94,091 48,787 39,212 26,946 31.84%
Ratio Analysis
31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
NP Margin -1,001.23 6,894.16 -859.99 -632.00 -639.76 -258.56 -241.95 26.67%
Per Share
31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
EPS -1.27 -1.46 -1.44 -1.09 -0.69 -0.57 -0.43 19.76%
EPS Diluted -1.27 -1.46 -1.44 -1.09 -0.69 -0.57 -0.43 19.76%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.